AlTi Global Inc. Buys 9,082 Shares of UnitedHealth Group Incorporated $UNH

AlTi Global Inc. grew its position in UnitedHealth Group Incorporated (NYSE:UNH) by 85.1% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 19,759 shares of the healthcare conglomerate’s stock after acquiring an additional 9,082 shares during the quarter. AlTi Global Inc.’s holdings in UnitedHealth Group were worth $6,823,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently modified their holdings of the business. Profund Advisors LLC grew its holdings in shares of UnitedHealth Group by 0.7% in the third quarter. Profund Advisors LLC now owns 15,748 shares of the healthcare conglomerate’s stock worth $5,438,000 after purchasing an additional 107 shares during the last quarter. Linden Thomas Advisory Services LLC raised its position in UnitedHealth Group by 2.8% during the 3rd quarter. Linden Thomas Advisory Services LLC now owns 4,836 shares of the healthcare conglomerate’s stock valued at $1,670,000 after purchasing an additional 134 shares in the last quarter. D.B. Root & Company LLC increased its stake in shares of UnitedHealth Group by 21.0% during the third quarter. D.B. Root & Company LLC now owns 2,050 shares of the healthcare conglomerate’s stock valued at $708,000 after buying an additional 356 shares during the period. REAP Financial Group LLC lifted its stake in UnitedHealth Group by 111.6% in the third quarter. REAP Financial Group LLC now owns 419 shares of the healthcare conglomerate’s stock worth $145,000 after acquiring an additional 221 shares during the period. Finally, LexAurum Advisors LLC raised its holdings in shares of UnitedHealth Group by 13.2% in the 3rd quarter. LexAurum Advisors LLC now owns 10,668 shares of the healthcare conglomerate’s stock valued at $3,684,000 after purchasing an additional 1,242 shares in the last quarter. Institutional investors own 87.86% of the company’s stock.

Wall Street Analysts Forecast Growth

Several analysts have issued reports on UNH shares. The Goldman Sachs Group began coverage on UnitedHealth Group in a research report on Tuesday, October 14th. They set a “buy” rating and a $406.00 target price on the stock. Barclays cut their price objective on shares of UnitedHealth Group from $391.00 to $327.00 and set an “overweight” rating on the stock in a research report on Friday, January 30th. TD Cowen upped their price target on UnitedHealth Group from $335.00 to $338.00 and gave the stock a “hold” rating in a research report on Thursday, October 30th. KeyCorp reissued an “overweight” rating on shares of UnitedHealth Group in a report on Wednesday, January 28th. Finally, UBS Group lowered their target price on shares of UnitedHealth Group from $430.00 to $410.00 and set a “buy” rating for the company in a research note on Wednesday, January 28th. One equities research analyst has rated the stock with a Strong Buy rating, seventeen have given a Buy rating, nine have given a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $372.13.

UnitedHealth Group Price Performance

NYSE:UNH opened at $275.17 on Tuesday. The firm has a market cap of $249.26 billion, a price-to-earnings ratio of 20.86, a PEG ratio of 1.27 and a beta of 0.41. The firm’s fifty day moving average is $324.91 and its two-hundred day moving average is $323.43. The company has a debt-to-equity ratio of 0.72, a quick ratio of 0.82 and a current ratio of 0.79. UnitedHealth Group Incorporated has a one year low of $234.60 and a one year high of $606.36.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, January 27th. The healthcare conglomerate reported $2.11 earnings per share for the quarter, beating the consensus estimate of $2.09 by $0.02. The company had revenue of $113.22 billion during the quarter, compared to analysts’ expectations of $113.38 billion. UnitedHealth Group had a return on equity of 14.79% and a net margin of 2.69%.UnitedHealth Group’s quarterly revenue was up 12.3% on a year-over-year basis. During the same period last year, the business earned $6.81 earnings per share. UnitedHealth Group has set its FY 2026 guidance at 17.750- EPS. Research analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

About UnitedHealth Group

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.